Kisqali and Nausea: What Users Say
Reviews for Kisqali
- Mum...
- Taken for 2 to 5 years
- March 16, 2021
For Breast Cancer, Metastatic "I have been on Kisqali since September 2018, with no disease progression. Tumor markers in the “normal” range. Side effects: nausea, diarrhea, joint pain, some hair loss in the early stages, the occasional rash or skin sensitivity, fatigue. Having said all of this, I am living my life, working full-time and traveling when possible... life is good!"
- DMa...
- Taken for 2 to 5 years
- November 9, 2020
For Breast Cancer, Metastatic "De novo diagnosis 3/21/18, started 600 mg with 2.5 mg Femara on 3/23/18. Single bone met on right humeral head. Complete remission in July 2019 (after 16 months). 32 months since diagnosis, still clear scans. Some hair thinning at first, along with occasional nausea, blurry vision (mostly in the AM), joint pain, and fatigue. Fatigue is the worst part for me, but my quality of life has not changed at all."
Frequently asked questions
- Does Kisqali improve survival / life expectancy for mBC?
- What are the benefits of taking Kisqali and Femara together?
- How do you take Kisqali?
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Kisqali (ribociclib)
- Kisqali consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (34)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CDK 4/6 inhibitors
- Breastfeeding
- En español
For Breast Cancer, Metastatic "Have been on Kisqali for two months. In the first week, three tablets every day, but due to side effects of diarrhea, nausea, and fatigue, reduced it to one. Still suffer the above, but not as severely. I do have Fulvestrant injections on a monthly basis. I am hoping with perseverance, side effects will decrease. I had breast cancer twenty-five years ago with metastasis in the last twelve, still not on the organs. I am 83 years old."